陳 儀聰

Medicine & Life Sciences

1. Nuclear Receptor Subfamily 2, Group C, Member 2 100%
2. MicroRNAs 80%
3. Orphan Nuclear Receptors 60%
4. Prostatic Neoplasms 51%
5. Familial Dysautonomia 47%
6. Circulating MicroRNA 46%
7. Androgen Receptors 45%
8. Heart Failure 43%
9. Natriuretic Peptides 39%
10. Androgens 33%
11. Genes 29%
12. Peptide Receptors 26%
13. Cerebellum 23%
14. Nuclear Receptor Subfamily 2, Group C, Member 1 21%
15. Developmental Gene Expression Regulation 19%
16. Proteins 19%
17. Mutation 18%
18. Survival 16%
19. Lanthanoid Series Elements 16%
20. mouse AR protein 16%
21. Ubiquitin-Specific Proteases 15%
22. Messenger RNA 15%
23. Ankyrin Repeat 15%
24. Deubiquitinating Enzymes 14%
25. Peroxisome Proliferator-Activated Receptors 14%
26. Prophase 14%
27. Apoptosis 14%
28. Biomarkers 14%
29. Progression-Free Survival 14%
30. Mitral Valve Prolapse 14%
31. Maternal Behavior 14%
32. Knockout Mice 13%
33. Globins 13%
34. Kinetin 13%
35. DNA Mismatch Repair 12%
36. Transcriptional Activation 12%
37. Phosphatidylinositol 3-Kinase 12%
38. Staphylococcal Protein A 12%
39. Spermatogenesis 11%
40. Cardiomegaly 11%
41. Prosencephalon 11%
42. Metabolic Diseases 11%
43. Stroke Volume 10%
44. Formal Social Control 10%
45. Insulin Resistance 10%
46. Heart Ventricles 10%
47. Urinary Bladder Neoplasms 10%
48. Neuregulins 9%
49. Nanoparticles 9%
50. Single Nucleotide Polymorphism 9%